Shirley Speakman

Prior to the IAF, Shirley spent over 10 years as an advisor to early-stage companies and venture capital funds, specializing on companies and funds focused in biotech, agricultural biotechnology (ag-biotech), and advanced manufacturing and materials. She participated in the creation of a $40 million cross-border life sciences fund and the close of a Canadian-based $40 million ag-biotech fund.